Xiaoru Hu

733 total citations
29 papers, 480 citations indexed

About

Xiaoru Hu is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Xiaoru Hu has authored 29 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 5 papers in Epidemiology. Recurrent topics in Xiaoru Hu's work include Chemotherapy-induced organ toxicity mitigation (7 papers), Renal and related cancers (4 papers) and Atmospheric aerosols and clouds (3 papers). Xiaoru Hu is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (7 papers), Renal and related cancers (4 papers) and Atmospheric aerosols and clouds (3 papers). Xiaoru Hu collaborates with scholars based in China, United States and Germany. Xiaoru Hu's co-authors include Zheng Dong, Siyao Li, Xiaohong Xiang, Chengyuan Tang, Qingqing Wei, Zhengwei Ma, Han‐Fei Ding, Lu Wen, Juan Cai and Man J. Livingston and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal Of Pathology.

In The Last Decade

Xiaoru Hu

27 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoru Hu China 12 194 147 75 69 68 29 480
Yunwen Yang China 15 216 1.1× 103 0.7× 100 1.3× 83 1.2× 79 1.2× 23 505
Shuqin Mei China 13 233 1.2× 160 1.1× 103 1.4× 74 1.1× 52 0.8× 22 531
Sujuan Xu China 13 180 0.9× 110 0.7× 52 0.7× 44 0.6× 26 0.4× 29 406
Xiujin Shen China 10 246 1.3× 136 0.9× 38 0.5× 46 0.7× 56 0.8× 17 419
Qi Bian China 13 322 1.7× 223 1.5× 85 1.1× 67 1.0× 73 1.1× 25 681
Lang Shi China 12 250 1.3× 83 0.6× 116 1.5× 48 0.7× 69 1.0× 24 448
Massimo Papale Italy 15 348 1.8× 161 1.1× 143 1.9× 45 0.7× 77 1.1× 30 676
Kefei Wu China 13 176 0.9× 74 0.5× 57 0.8× 32 0.5× 47 0.7× 26 471
Xianjin Bi China 15 268 1.4× 296 2.0× 57 0.8× 53 0.8× 71 1.0× 18 649
Jiejun Wen China 10 176 0.9× 213 1.4× 36 0.5× 52 0.8× 47 0.7× 14 463

Countries citing papers authored by Xiaoru Hu

Since Specialization
Citations

This map shows the geographic impact of Xiaoru Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoru Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoru Hu more than expected).

Fields of papers citing papers by Xiaoru Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoru Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoru Hu. The network helps show where Xiaoru Hu may publish in the future.

Co-authorship network of co-authors of Xiaoru Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoru Hu. A scholar is included among the top collaborators of Xiaoru Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoru Hu. Xiaoru Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ying, Yuqing Zeng, Ying Fu, et al.. (2025). Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair. Kidney International. 107(5). 869–887. 5 indexed citations
2.
Chen, Yihong, Bin Zhang, Shiwei Shi, et al.. (2024). TPTU-v2: Boosting Task Planning and Tool Usage of Large Language Model-based Agents in Real-world Industry Systems. 371–385. 3 indexed citations
3.
Wei, Qingqing, Xiao Xiao, Chunyuan Guo, et al.. (2024). Hypermethylation and suppression of microRNA219a-2 activates the ALDH1L2/GSH/PAI-1 pathway for fibronectin degradation in renal fibrosis. Molecular Therapy. 33(1). 249–262. 2 indexed citations
4.
Su, Debin, et al.. (2024). Innovative cloud quantification: deep learning classification and finite-sector clustering for ground-based all-sky imaging. Atmospheric measurement techniques. 17(12). 3765–3781. 2 indexed citations
5.
Zhao, Wei, Yinan Wang, Lingxiao Wu, et al.. (2024). Unveiling Cloud Vertical Structures over the Interior Tibetan Plateau through Anomaly Detection in Synergetic Lidar and Radar Observations. Advances in Atmospheric Sciences. 41(12). 2381–2398.
6.
Li, Siyao, Man J. Livingston, Xiaoru Hu, et al.. (2023). Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. JCI Insight. 8(8). 60 indexed citations
7.
Chen, Xiaoyu, et al.. (2023). Chiral NHC‐Catalyzed [4+2] Cycloadditions: Highly Diastereo/Enantioselective Access to Spiro[cyclohex‐4‐ene‐1,3′‐indoles] and DFT Calculations. Chemistry - A European Journal. 29(23). e202203818–e202203818. 3 indexed citations
8.
Zhang, Zhanjun, Xiaoru Hu, Haoyu Zhang, & Jie Liu. (2023). NEDORT: a novel and efficient approach to the data overlap problem in relational triples. Complex & Intelligent Systems. 9(5). 5235–5250. 3 indexed citations
9.
Wu, Lingxiao, T. L. Chen, Ming Li, et al.. (2023). Development of a Machine Learning Forecast Model for Global Horizontal Irradiation Adapted to Tibet Based on Visible All-Sky Imaging. Remote Sensing. 15(9). 2340–2340. 5 indexed citations
10.
Hu, Xiaoru, Zhengwei Ma, Siyao Li, et al.. (2023). Fibroblast Growth Factor 2 Is Produced By Renal Tubular Cells to Act as a Paracrine Factor in Maladaptive Kidney Repair After Cisplatin Nephrotoxicity. Laboratory Investigation. 103(3). 100009–100009. 2 indexed citations
11.
Zhao, Guangyue, Xiaoru Hu, Yun Qiao, et al.. (2023). Universal screening for Lynch syndrome in operated colorectal cancer by immunohistochemistry: a cohort of patients in Liaoning province, China. European Journal of Cancer Prevention. 32(4). 337–347.
12.
Wei, Qingqing, Man J. Livingston, Guie Dong, et al.. (2022). PFKFB3 mediates tubular cell death in cisplatin nephrotoxicity by activating CDK4. Translational research. 253. 31–40. 11 indexed citations
13.
Wang, Xiaofang, et al.. (2022). The Prognostic Role of Glycemia in Patients With Pancreatic Carcinoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 12. 780909–780909. 7 indexed citations
14.
Ma, Zhengwei, Xiaoru Hu, Han‐Fei Ding, et al.. (2022). Single-Nucleus Transcriptional Profiling of Chronic Kidney Disease after Cisplatin Nephrotoxicity. American Journal Of Pathology. 192(4). 613–628. 21 indexed citations
15.
Wen, Lu, Ying Li, Siyao Li, et al.. (2021). Glucose Metabolism in Acute Kidney Injury and Kidney Repair. Frontiers in Medicine. 8. 744122–744122. 44 indexed citations
16.
Zhang, Mingming, et al.. (2021). Association between fasting blood glucose levels at admission and overall survival of patients with pancreatic cancer. BMC Cancer. 21(1). 131–131. 7 indexed citations
17.
Liu, Zhiwen, Danyi Yang, Jingli Gao, et al.. (2020). Discovery and validation of miR-452 as an effective biomarker for acute kidney injury in sepsis. Theranostics. 10(26). 11963–11975. 90 indexed citations
18.
Cai, Juan, Zhiwen Liu, Xian Huang, et al.. (2019). The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression. Kidney International. 97(1). 106–118. 72 indexed citations
19.
Shao, Zhiying, et al.. (2015). P175 Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in MBC. The Breast. 24. S85–S85. 1 indexed citations
20.
Zhou, Qi, et al.. (2007). Role of Interleukin-6 in the Pathogenesis of an Avian Model of Staphylococcus aureus Arthritis. Poultry Science. 86(6). 1245–1250. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026